Quarterly Result2 Nov 2026, 05:31 pm
Shree Ganesh Biotech Declares Un-audited Q2 FY27 Results
AI Summary
Shree Ganesh Biotech (India) Ltd announced its un-audited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results in a meeting held on November 2, 2026. The company reported a net loss after tax for the quarter and half-year. The statutory auditors have carried out a limited review of the financial results.
Key Highlights
- Board approved un-audited financial results for Q2 and H1 FY27.
- Results for the quarter and half-year ended September 30, 2026, were declared.
- The company reported a net loss for the period.
- A limited review was conducted by the statutory auditors.
- The Board meeting concluded on November 2, 2026.
Price Impact
More from SHREEGANES